Skip to main content

Headaches, Migraine, and Cluster Headache

  • Chapter
  • First Online:
Orofacial Pain

Abstract

Headache is the leading reason for medical consultation and particularly for neurological consultation. A tremendous range of disorders can present with headaches. A systemic approach to headache classification and diagnosis is therefore essential both for clinical management and research. Epidemiology is the study of diseases, their risk factors, causes, natural history, and burden in the population. While epidemiologic studies are often population based, this is particularly important for headache because the disorder is often under-ascertained in the health care system. Most patients with headache can be diagnosed simply from a good history and general and neuralgic examinations. In some cases, however, diagnostic testing is necessary to distinguish primary causes from secondary ones, which may share similar features. The differential diagnosis of headache is one of the longest in all of medicine with more than 300 different types and causes. We offer an algorithmic approach to primary headache diagnosis based on attack frequency and duration, using the second edition of ICHD-2 classification (Headache Classification Committee of the International Headache Society 2004) highlighting the primary headache disorders and their diagnostic criteria. Recurrent headache disorders impose a substantial burden on individual headache sufferers, on their families, and on societies. Headache disorders are divided into secondary disorders, attributed to an underlying condition, and primary disorders, such as migraine, trigeminal autonomic cephalalgias, and tension-type headaches, where there is no underlying cause. The epidemiology of secondary headache is largely determined by the epidemiology of the underlying cause. Therefore in this chapter we focus on the epidemiology of primary headache disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9–160.

    Google Scholar 

  2. Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia. 1991;11:129–34.

    Article  CAS  PubMed  Google Scholar 

  3. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445–50.

    Article  CAS  PubMed  Google Scholar 

  4. Schoenen J, Gerard P, Pasqua D, VJuprelle M. EMG activity in pericranial muscles during postural variation and mental activity in healthy volunteers and patients with chronic tension type headache. Headache. 1991;31:321–4.

    Article  CAS  PubMed  Google Scholar 

  5. Feuerstein M, Bush C, Corbisiero R. Stress and chronic headache: a psychophysiological analysis of mechanisms. J Psychosom Res. 1982;26:167–82.

    Article  CAS  PubMed  Google Scholar 

  6. Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain. 1991;46(2):125–32.

    Article  CAS  PubMed  Google Scholar 

  7. Jensen R. Mechanisms of tension-type headache. Cephalalgia. 2001;21:786–9.

    Article  CAS  PubMed  Google Scholar 

  8. Lipton RB, Stewart WF, Cady R, et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000;40(10):783–91.

    Article  CAS  PubMed  Google Scholar 

  9. Penzien DB, Rains JC, Lipchik GL, Creer TL. Behavioral interventions for tension-type headache: overview of current therapies and recommendation for a self-management model for chronic headache. Curr Pain Headache Rep. 2004;8:489–99.

    Article  PubMed  Google Scholar 

  10. Graff-Radford SB, Reeves JL, Jaeger B. Management of chronic head and neck pain: effectiveness of altering factors perpetuating myofascial pain. Headache. 1987;27:186–90.

    Article  CAS  PubMed  Google Scholar 

  11. Agostoni E, Aliprandi A. The complications of migraine with aura. Neurol Sci. 2006;27 Suppl 2:S91–5.

    Article  PubMed  Google Scholar 

  12. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache. 2007;47:355–63.

    PubMed  Google Scholar 

  13. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache. 2003;43:19–26.

    Article  PubMed  Google Scholar 

  14. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology. 1996;47:52–9.

    Article  CAS  PubMed  Google Scholar 

  15. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.

    Article  CAS  PubMed  Google Scholar 

  16. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemo-graphic factors. JAMA. 1992;267:64–9.

    Article  CAS  PubMed  Google Scholar 

  17. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638–45.

    Article  CAS  PubMed  Google Scholar 

  18. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin. 1990;8:801–15.

    CAS  PubMed  Google Scholar 

  19. Longoni M, Ferrarese C. Inflammation and excito-toxicity: role in migraine pathogenesis. Neurol Sci. 2006;27 Suppl 2:S107–10.

    Article  PubMed  Google Scholar 

  20. Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44(1):53–64.

    Article  PubMed  Google Scholar 

  21. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia. 2006;26(4):361–72.

    Article  CAS  PubMed  Google Scholar 

  22. Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006;46 Suppl 4:S182–91.

    Article  PubMed  Google Scholar 

  23. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.

    Article  CAS  PubMed  Google Scholar 

  24. Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006;26(2):199–207.

    Article  PubMed  Google Scholar 

  25. Ramadan NM. Current trends in migraine prophylaxis. Headache. 2007;47(1):S52–7.

    Article  PubMed  Google Scholar 

  26. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev. 2004;3, CD003226.

    PubMed  Google Scholar 

  27. Conway S, Delplanche C, Crowder J, Rothrock J. Botox therapy for refractory chronic migraine. Headache. 2005;45:355–7.

    Article  PubMed  Google Scholar 

  28. Binder WJ, Brin MF, Blitzer A, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine. Dis Mon. 2002;48:323–35.

    Article  PubMed  Google Scholar 

  29. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–8.

    Article  CAS  PubMed  Google Scholar 

  30. Manzoni GC. Gender ratio of cluster headache over the years: a possible role of changes in lifestyle. Cephalalgia. 1998;18(3):138–42.

    Article  CAS  PubMed  Google Scholar 

  31. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology. 2002;58(3):354–61.

    Article  PubMed  Google Scholar 

  32. Ekbom K, Ahlborg B, Scheie R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache. 1978;18(1):9–19.

    Article  CAS  PubMed  Google Scholar 

  33. Torelli P, Castellini P, Cucurachi L, Devetak M, Lam-bru G, Manzoni GC. Cluster headache prevalence: methodological considerations. A review of the literature. Acta Biomed. 2006;77(1):4–9.

    PubMed  Google Scholar 

  34. Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia. 1993;13:309–17.

    Article  CAS  PubMed  Google Scholar 

  35. Chervin RD, Zallek SN, Lin X, Hall JM, Sharma N, Hedger KM. Sleep disordered breathing in patients with cluster headache. Neurology. 2000;54:2302–6.

    Article  CAS  PubMed  Google Scholar 

  36. Graff-Radford SB, Newman A. Obstructive sleep apnea and cluster headache. Headache. 2004;44:607–10.

    Article  PubMed  Google Scholar 

  37. Kudrow L. A possible role of the carotid body in the pathogenesis of cluster headache. Cephalalgia. 1983;3:241–7.

    Article  CAS  PubMed  Google Scholar 

  38. Capobianco DJ, Dodick DW. Diagnosis and treatment of cluster headache. Semin Neurol. 2006;26:242–59.

    Article  PubMed  Google Scholar 

  39. May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13:1066–77.

    Article  CAS  PubMed  Google Scholar 

  40. Pascual J, Lainez MJ, Dodick D, Hering-Hanit R. Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review. Headache. 2007;47:S1–89.

    Article  Google Scholar 

  41. Taha JM, Tew Jr JM. Long-term results of radiofrequency rhizotomy in the treatment of cluster headache. Headache. 1995;35:193–6.

    Article  CAS  PubMed  Google Scholar 

  42. Lovely TJ, Kotsiakis X, Jannetta PJ. The surgical management of chronic cluster headache. Headache. 1998;38:590–4.

    Article  CAS  PubMed  Google Scholar 

  43. McClelland 3rd S, Barnett GH, Neyman G, Suh JH. Repeat trigeminal nerve radiosurgery for refractory cluster headache fails to provide long-term pain relief. Headache. 2007;47:298–300.

    Article  PubMed  Google Scholar 

  44. Starr PA, Barbara NM, Raskin NH, Ostrem JL. Chronic stimulation of the posterior hypothalamic region for cluster headache: technique and 1-year results in four patients. J Neurosurg. 2007;106:999–1005.

    Article  PubMed  Google Scholar 

  45. Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007;369:1099–106.

    Article  PubMed  Google Scholar 

  46. Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology. 2006;67:150–2.

    Article  PubMed  Google Scholar 

  47. Matharu MS, Goadsby PJ. Functional brain imaging in hemicrania continua: implications for nosology and pathophysiology. Curr Pain Headache Rep. 2005;9:281–8.

    Article  CAS  PubMed  Google Scholar 

  48. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the ‘indotest’. Headache. 1998;38:122–8.

    Article  CAS  PubMed  Google Scholar 

  49. Pascual J, Quijano J. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan. J Neurol Neurosurg Psychiatry. 1998;65:407.

    Article  CAS  PubMed  Google Scholar 

  50. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan. Headache. 1998;38:197–200.

    Article  CAS  PubMed  Google Scholar 

  51. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry. 2007;78:96–7.

    Article  CAS  PubMed  Google Scholar 

  52. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiratnate. J Neurol Neurosurg Psychiatry. 2007;78:96–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

None declared.

Conflict of Interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghabi A. Kaspo D.D.S., D. Orth. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland 2014

About this chapter

Cite this chapter

Kaspo, G.A. (2014). Headaches, Migraine, and Cluster Headache. In: Vadivelu, N., Vadivelu, A., Kaye, A. (eds) Orofacial Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-01875-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-01875-1_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-01874-4

  • Online ISBN: 978-3-319-01875-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics